Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Alkaliphilus metalliredigens Ribosome-binding factor A (rbfA) CSB-YP412614AUP
CSB-EP412614AUP
CSB-BP412614AUP
CSB-MP412614AUP
CSB-EP412614AUP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus metalliredigens Phosphate acyltransferase (plsX) CSB-YP412615AUP
CSB-EP412615AUP
CSB-BP412615AUP
CSB-MP412615AUP
CSB-EP412615AUP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus metalliredigens Ribosomal RNA small subunit methyltransferase H 1 (rsmH1) CSB-YP412616AUP
CSB-EP412616AUP
CSB-BP412616AUP
CSB-MP412616AUP
CSB-EP412616AUP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus metalliredigens UPF0317 protein Amet_2975 (Amet_2975) CSB-YP412617AUP
CSB-EP412617AUP
CSB-BP412617AUP
CSB-MP412617AUP
CSB-EP412617AUP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus metalliredigens Chaperone protein DnaK (dnaK), partial CSB-YP412618AUP
CSB-EP412618AUP
CSB-BP412618AUP
CSB-MP412618AUP
CSB-EP412618AUP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus metalliredigens Imidazolonepropionase (hutI) CSB-YP412619AUP
CSB-EP412619AUP
CSB-BP412619AUP
CSB-MP412619AUP
CSB-EP412619AUP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus metalliredigens Glutamyl-tRNA (Gln) amidotransferase subunit A CSB-YP412620AUP
CSB-EP412620AUP
CSB-BP412620AUP
CSB-MP412620AUP
CSB-EP412620AUP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus metalliredigens Protein translocase subunit SecA 2 (secA2), partial CSB-YP412621AUP
CSB-EP412621AUP
CSB-BP412621AUP
CSB-MP412621AUP
CSB-EP412621AUP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus metalliredigens HPr kinase/phosphorylase (hprK) CSB-YP412622AUP
CSB-EP412622AUP
CSB-BP412622AUP
CSB-MP412622AUP
CSB-EP412622AUP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus metalliredigens Aspartate carbamoyltransferase (pyrB) CSB-YP412623AUP
CSB-EP412623AUP
CSB-BP412623AUP
CSB-MP412623AUP
CSB-EP412623AUP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus metalliredigens Phosphoglucosamine mutase (glmM) CSB-YP412624AUP
CSB-EP412624AUP
CSB-BP412624AUP
CSB-MP412624AUP
CSB-EP412624AUP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus metalliredigens 30S ribosomal protein S9 (rpsI) CSB-YP412625AUP
CSB-EP412625AUP
CSB-BP412625AUP
CSB-MP412625AUP
CSB-EP412625AUP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus metalliredigens DNA-directed RNA polymerase subunit alpha (rpoA) CSB-YP412626AUP
CSB-EP412626AUP
CSB-BP412626AUP
CSB-MP412626AUP
CSB-EP412626AUP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus metalliredigens 50S ribosomal protein L14 (rplN) CSB-YP412627AUP
CSB-EP412627AUP
CSB-BP412627AUP
CSB-MP412627AUP
CSB-EP412627AUP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus metalliredigens 30S ribosomal protein S3 (rpsC) CSB-YP412628AUP
CSB-EP412628AUP
CSB-BP412628AUP
CSB-MP412628AUP
CSB-EP412628AUP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus metalliredigens 30S ribosomal protein S10 (rpsJ) CSB-YP412629AUP
CSB-EP412629AUP
CSB-BP412629AUP
CSB-MP412629AUP
CSB-EP412629AUP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus metalliredigens 50S ribosomal protein L10 (rplJ) CSB-YP412630AUP
CSB-EP412630AUP
CSB-BP412630AUP
CSB-MP412630AUP
CSB-EP412630AUP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus metalliredigens Type III pantothenate kinase (coaX) CSB-YP412631AUP
CSB-EP412631AUP
CSB-BP412631AUP
CSB-MP412631AUP
CSB-EP412631AUP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus metalliredigens Ribosomal RNA large subunit methyltransferase H (rlmH) CSB-YP412632AUP
CSB-EP412632AUP
CSB-BP412632AUP
CSB-MP412632AUP
CSB-EP412632AUP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus metalliredigens UPF0133 protein Amet_4780 (Amet_4780) CSB-YP412633AUP
CSB-EP412633AUP
CSB-BP412633AUP
CSB-MP412633AUP
CSB-EP412633AUP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>